These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25996892)

  • 1. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial.
    Baserga MC; Beachy JC; Roberts JK; Ward RM; DiGeronimo RJ; Walsh WF; Ohls RK; Anderson J; Mayock DE; Juul SE; Christensen RD; Loertscher MC; Stockmann C; Sherwin CM; Spigarelli MG; Yoder BA
    Pediatr Res; 2015 Sep; 78(3):315-22. PubMed ID: 25996892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy.
    Roberts JK; Stockmann C; Ward RM; Beachy J; Baserga MC; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2015 Dec; 54(12):1237-44. PubMed ID: 25989868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing.
    An G; Ohls RK; Christensen RD; Widness JA; Mock DM; Veng-Pedersen P
    J Pharm Sci; 2017 Jun; 106(6):1644-1649. PubMed ID: 28189627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.
    Ohls RK; Kamath-Rayne BD; Christensen RD; Wiedmeier SE; Rosenberg A; Fuller J; Lacy CB; Roohi M; Lambert DK; Burnett JJ; Pruckler B; Peceny H; Cannon DC; Lowe JR
    Pediatrics; 2014 Jun; 133(6):1023-30. PubMed ID: 24819566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Darbepoetin as a neuroprotective agent in mild neonatal encephalopathy: a randomized, placebo-controlled, feasibility trial.
    DuPont TL; Baserga M; Lowe J; Zamora T; Beauman S; Ohls RK
    J Perinatol; 2021 Jun; 41(6):1339-1346. PubMed ID: 33986477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Juul SE; Massaro AN; Bammler TK; Wu YW
    Pediatr Res; 2017 Jun; 81(6):865-872. PubMed ID: 28099423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
    Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
    Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darbepoetin alfa: a novel erythropoiesis-stimulating protein.
    Joy MS
    Ann Pharmacother; 2002; 36(7-8):1183-92. PubMed ID: 12086553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darbepoetin Administration in Term and Preterm Neonates.
    Patel S; Ohls RK
    Clin Perinatol; 2015 Sep; 42(3):557-66. PubMed ID: 26250917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
    Rogers EE; Bonifacio SL; Glass HC; Juul SE; Chang T; Mayock DE; Durand DJ; Song D; Barkovich AJ; Ballard RA; Wu YW
    Pediatr Neurol; 2014 Nov; 51(5):657-62. PubMed ID: 25439577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease.
    Lerner G; Kale AS; Warady BA; Jabs K; Bunchman TE; Heatherington A; Olson K; Messer-Mann L; Maroni BJ
    Pediatr Nephrol; 2002 Nov; 17(11):933-7. PubMed ID: 12432437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of darbepoetin to NICU patients.
    Warwood TL; Ohls RK; Lambert DK; Jones C; Scoffield SH; Gupta N; Veng-Pedersen P; Christensen RD
    J Perinatol; 2006 May; 26(5):296-300. PubMed ID: 16554846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.
    Hernandez E; Ganly P; Charu V; Dibenedetto J; Tomita D; Lillie T; Taylor K;
    Curr Med Res Opin; 2009 Sep; 25(9):2109-20. PubMed ID: 19601709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.
    Ohls RK; Cannon DC; Phillips J; Caprihan A; Patel S; Winter S; Steffen M; Yeo RA; Campbell R; Wiedmeier S; Baker S; Gonzales S; Lowe J
    Pediatrics; 2016 Mar; 137(3):e20153859. PubMed ID: 26908704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose darbepoetin administration to anemic preterm neonates.
    Warwood TL; Ohls RK; Wiedmeier SE; Lambert DK; Jones C; Scoffield SH; Neeraj G; Veng-Pedersen P; Christensen RD
    J Perinatol; 2005 Nov; 25(11):725-30. PubMed ID: 16151471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
    Blumer J; Berg S; Adamson PC; Loew T; Rossi G; Hastings C
    Pediatr Blood Cancer; 2007 Oct; 49(5):687-93. PubMed ID: 17120240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Neutropenia in Preterm Neonates Following Administration of Darbepoetin Alfa.
    Andrews N; Friedman S; Dunham M; Dean R; Chabra S
    J Pediatr Pharmacol Ther; 2023; 28(1):41-47. PubMed ID: 36777988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.